Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Sparta expands clinical trials of retinoid

Feb. 11, 1997

Sumitomo develops ACAT inhibitors

Feb. 11, 1997

Hypoglycemic/hypolipidemic agents from Kyorin

Feb. 11, 1997

Sankyo develops antidiabetic agents

Feb. 11, 1997

Structure of protease involved in osteoporosis solved

Feb. 10, 1997

Unigene Laboratories reveals bioequivalency results for osteoporosis drug

Feb. 7, 1997

Alza signs licensing agreements for transdermal testesterone products

Feb. 7, 1997

Progress in Bone Care's vitamin D pipeline

Feb. 7, 1997

Nonantiresorptive substituted bisphosphonate disclosed by Gador

Feb. 7, 1997

FDA approval for Ferring antifertility Rx

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.